300452 山河药辅
已收盘 09-02 15:00:00
资讯
新帖
简况
山河药辅(300452)2025年中报简析:增收不增利
证券之星 · 08-27
山河药辅(300452)2025年中报简析:增收不增利
药企龙头山河药辅突发公告,60岁董事长逝世,当日上午还在主持会议
21世纪经济报道 · 08-27
药企龙头山河药辅突发公告,60岁董事长逝世,当日上午还在主持会议
山河药辅:公司控股股东、实控人、董事长尹正龙逝世
金融界 · 08-27
山河药辅:公司控股股东、实控人、董事长尹正龙逝世
山河药辅表示董事长尹正龙于8月26日去世,经营不会受到影响
美股速递 · 08-27
山河药辅表示董事长尹正龙于8月26日去世,经营不会受到影响
山河药辅(300452.SZ)发布上半年业绩,归母净利润9303.52万元,下降2.61%
智通财经 · 08-26
山河药辅(300452.SZ)发布上半年业绩,归母净利润9303.52万元,下降2.61%
山河药辅(300452.SZ)新增1种药用辅料产品
智通财经 · 08-04
山河药辅(300452.SZ)新增1种药用辅料产品
山河药辅最新公告:与淮南经济技术开发区管理委员会签订高端辅料智造基地项目投资协议书
证券之星 · 07-31
山河药辅最新公告:与淮南经济技术开发区管理委员会签订高端辅料智造基地项目投资协议书
7月1日山河药辅(300452)龙虎榜数据:游资瑞鹤仙上榜
证券之星 · 07-01
7月1日山河药辅(300452)龙虎榜数据:游资瑞鹤仙上榜
【化学制药板块持续走高,山河药辅、灵康药业涨停】 化学制药板块持续走高,山河药辅、灵康药业涨停,北陆药业、翰宇药业、永安药业、星昊医药、哈三联等跟涨。
金融界 · 07-01
【化学制药板块持续走高,山河药辅、灵康药业涨停】 化学制药板块持续走高,山河药辅、灵康药业涨停,北陆药业、翰宇药业、永安药业、星昊医药、哈三联等跟涨。
异动快报:山河药辅(300452)7月1日9点44分触及涨停板
证券之星 · 07-01
异动快报:山河药辅(300452)7月1日9点44分触及涨停板
6月16日山河药辅发布公告,股东减持161.7万股
证券之星 · 06-16
6月16日山河药辅发布公告,股东减持161.7万股
山河药辅收盘下跌1.00%,滚动市盈率23.77倍,总市值27.76亿元
金融界 · 04-29
山河药辅收盘下跌1.00%,滚动市盈率23.77倍,总市值27.76亿元
山河药辅:作为国内药用辅料的领先者坚决作好制药企业应对国际变局的坚实后盾
证券之星 · 04-25
山河药辅:作为国内药用辅料的领先者坚决作好制药企业应对国际变局的坚实后盾
仿制药概念股回调,科伦药业跌逾5%,华东医药、海思科、山河药辅跌逾4%。
金融界 · 04-25
仿制药概念股回调,科伦药业跌逾5%,华东医药、海思科、山河药辅跌逾4%。
山河药辅(300452.SZ)发布2024年度业绩,归母净利润1.19亿元,同比下降26.07%
智通财经 · 04-22
山河药辅(300452.SZ)发布2024年度业绩,归母净利润1.19亿元,同比下降26.07%
再出手!复星医药产业拟减持山河药辅,这一次套现多少?
投资时报 · 02-25
再出手!复星医药产业拟减持山河药辅,这一次套现多少?
复星医药拟减持山河药辅不超3%股份市值腰斩聚焦核心业务加注AI医药
新浪财经 · 02-24
复星医药拟减持山河药辅不超3%股份市值腰斩聚焦核心业务加注AI医药
山河药辅:股东复星医药因经营需要拟减持不超过3%公司股份
观点网 · 02-23
山河药辅:股东复星医药因经营需要拟减持不超过3%公司股份
山河药辅(300452.SZ)股东复星医药拟减持不超3%股份
智通财经 · 02-23
山河药辅(300452.SZ)股东复星医药拟减持不超3%股份
加载更多
公司概况
公司名称:
安徽山河药用辅料股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-15
主营业务:
安徽山河药用辅料股份有限公司的主营业务是药用辅料的研发、生产和销售。公司的主要产品是填充剂、黏合剂、崩解剂、润滑剂、包衣材料。“立崩”牌羧甲淀粉钠先后获得淮南市知名产品、安徽省名牌产品和“中国化学制药行业药用辅料优秀产品品牌”、首批“安徽工业精品”称号,羟丙甲纤维素荣获“中国化学制药行业优秀产品品牌”奖。微晶纤维素、硬脂酸镁和薄膜包衣粉产品被评定为淮南市知名产品,并有多个产品列入《中国高新技术产品出口目录》。公司多次获得“中国化学行业药用辅料优秀企业品牌”称号。
发行价格:
14.96
{"stockData":{"symbol":"300452","market":"SZ","secType":"STK","nameCN":"山河药辅","latestPrice":13.52,"timestamp":1756796592000,"preClose":13.67,"halted":0,"volume":5922069,"delay":0,"changeRate":-0.011,"floatShares":187000000,"shares":234000000,"eps":0.4988,"marketStatus":"已收盘","change":-0.15,"latestTime":"09-02 15:00:00","open":13.65,"high":13.65,"low":13.36,"amount":79927400,"amplitude":0.0212,"askPrice":13.52,"askSize":228,"bidPrice":13.51,"bidSize":47,"shortable":0,"etf":0,"ttmEps":0.4988,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756863000000},"marketStatusCode":5,"adr":0,"adjPreClose":13.67,"symbolType":"stock","openAndCloseTimeList":[[1756776600000,1756783800000],[1756789200000,1756796400000]],"highLimit":15.04,"lowLimit":12.3,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":234449487,"isCdr":false,"pbRate":3.59,"roa":"--","peRate":27.105052,"roe":"9.8%","epsLYR":0.51,"committee":0.186063,"marketValue":3170000000,"turnoverRate":0.0317,"status":1,"floatMarketCap":2526000000},"requestUrl":"/m/hq/s/300452","defaultTab":"news","newsList":[{"id":"2562677655","title":"山河药辅(300452)2025年中报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2562677655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562677655?lang=zh_cn&edition=full","pubTime":"2025-08-28 06:28","pubTimestamp":1756333712,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期山河药辅发布2025年中报。根据财报显示,山河药辅增收不增利。截至本报告期末,公司营业总收入4.71亿元,同比上升4.65%,归母净利润9303.52万元,同比下降2.61%。按单季度数据看,第二季度营业总收入2.23亿元,同比上升5.06%,第二季度归母净利润4585.83万元,同比上升0.31%。本次财报公布的各项数据指标表现一般。投资活动产生的现金流量净额变动幅度为-176.15%,原因:本报告期购买理财产品支付现金及建设工程项目支付资金增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800006446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0177","BK0239","300452"],"gpt_icon":0},{"id":"2562910917","title":"药企龙头山河药辅突发公告,60岁董事长逝世,当日上午还在主持会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2562910917","media":"21世纪经济报道","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562910917?lang=zh_cn&edition=full","pubTime":"2025-08-27 13:37","pubTimestamp":1756273020,"startTime":"0","endTime":"0","summary":" 27日上午,山河药辅突发公告,公司控股股东、实际控制人、董事长尹正龙先生于2025年8月26日下午逝世,享年60岁。 21财经·南财快讯记者留意到,根据山河药辅发布的《第六届董事会第七次会议决议公告》,尹正龙逝世当日上午,还主持了公司第六届董事会第七次会议。 山河药辅表示,尹正龙所持的公司股份将按相关法律法规办理相关手续,公司将根据后续事项进展情况及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2025-08-27/doc-infnkyff7470594.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-08-27/doc-infnkyff7470594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"2562534761","title":"山河药辅:公司控股股东、实控人、董事长尹正龙逝世","url":"https://stock-news.laohu8.com/highlight/detail?id=2562534761","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562534761?lang=zh_cn&edition=full","pubTime":"2025-08-27 08:22","pubTimestamp":1756254152,"startTime":"0","endTime":"0","summary":"山河药辅公告,公司控股股东、实控人、董事长尹正龙已于2025年8月26日下午逝世,享年60岁。尹正龙持有公司股份约6305.75万股,占公司股份总额的26.9%。尹正龙所持的公司股份将按相关法律法规办理相关手续,公司将根据后续事项进展情况及时履行信披义务。经全体董事推举,现由公司董事、总经理宋道才暂行行使公司董事长和法定代表人职责,直至公司董事会选举出新的董事长之日止。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/27082252721718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","300452","BK0177"],"gpt_icon":0},{"id":"1180223002","title":"山河药辅表示董事长尹正龙于8月26日去世,经营不会受到影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1180223002","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180223002?lang=zh_cn&edition=full","pubTime":"2025-08-27 08:12","pubTimestamp":1756253536,"startTime":"0","endTime":"0","summary":"山河药辅表示董事长尹正龙于8月26日去世,经营不会受到影响","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0177","BK0239","300452"],"gpt_icon":0},{"id":"2562785413","title":"山河药辅(300452.SZ)发布上半年业绩,归母净利润9303.52万元,下降2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562785413","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562785413?lang=zh_cn&edition=full","pubTime":"2025-08-26 16:27","pubTimestamp":1756196854,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)发布2025年半年度报告,该公司营业收入为4.71亿元,同比增长4.65%。归属于上市公司股东的净利润为9303.52万元,同比减少2.61%。归属于上市公司股东的扣除非经常性损益的净利润为8475.4万元,同比增长6.05%。基本每股收益为0.4元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1335237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300452"],"gpt_icon":0},{"id":"2556809041","title":"山河药辅(300452.SZ)新增1种药用辅料产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2556809041","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556809041?lang=zh_cn&edition=full","pubTime":"2025-08-04 16:37","pubTimestamp":1754296652,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)公告,公司新增1种药用辅料产品:甘露醇丸芯获得国家药品监督管理局药品审评中心(简称“CDE”)的登记号,为F20250000241。甘露醇丸芯是由D-甘露糖醇及其他辅料制成的白色或类白色球形小丸,主要用作肠溶微丸制剂和缓控释微丸制剂的载体,也可直接作为药物微丸。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325349.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0177","BK0239","300452"],"gpt_icon":0},{"id":"2555788945","title":"山河药辅最新公告:与淮南经济技术开发区管理委员会签订高端辅料智造基地项目投资协议书","url":"https://stock-news.laohu8.com/highlight/detail?id=2555788945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555788945?lang=zh_cn&edition=full","pubTime":"2025-07-31 18:31","pubTimestamp":1753957902,"startTime":"0","endTime":"0","summary":"山河药辅(300452.SZ)公告称,公司与淮南经济技术开发区管理委员会签订《高端辅料智造基地项目投资协议书》,拟在淮南经开化工园区投资建设高端辅料智造基地,项目投资额约10.5亿元人民币,其中固定资产投资6亿元人民币。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073100031188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0177","BK0239","300452"],"gpt_icon":0},{"id":"2548072859","title":"7月1日山河药辅(300452)龙虎榜数据:游资瑞鹤仙上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2548072859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548072859?lang=zh_cn&edition=full","pubTime":"2025-07-01 17:21","pubTimestamp":1751361714,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月1日公布的交易公开信息显示,山河药辅因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月1日收盘,山河药辅报收于14.72元,上涨19.97%,涨停,换手率32.06%,成交量59.89万手,成交额8.58亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入833.62万元。瑞鹤仙等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100028970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300452","BK0177","BK0239"],"gpt_icon":0},{"id":"2548403630","title":"【化学制药板块持续走高,山河药辅、灵康药业涨停】 化学制药板块持续走高,山河药辅、灵康药业涨停,北陆药业、翰宇药业、永安药业、星昊医药、哈三联等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548403630","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548403630?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:52","pubTimestamp":1751334762,"startTime":"0","endTime":"0","summary":"化学制药板块持续走高,山河药辅、灵康药业涨停,北陆药业、翰宇药业、永安药业、星昊医药、哈三联等跟涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/01095251401634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","BK0077","BK0033","603669","BK1574","002900","BK0042","BK0060","BK0086","BK0177","300016","BK0046","300452","BK1161","BK0239","300199","BK1191","09939","002365","01477","BK0188","BK0070","BK1515","BK0056","159938"],"gpt_icon":0},{"id":"2548047705","title":"异动快报:山河药辅(300452)7月1日9点44分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2548047705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548047705?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:45","pubTimestamp":1751334329,"startTime":"0","endTime":"0","summary":"证券之星7月1日盘中消息,9点44分山河药辅触及涨停板。目前价格14.72,上涨19.97%。其所属行业化学制药目前上涨。领涨股为山河药辅。该股为化学原料药,医药,新冠药物概念热股,当日化学原料药概念上涨0.96%,医药概念上涨0.88%。6月30日的资金流向数据方面,主力资金净流入183.69万元,占总成交额3.73%,游资资金净流出179.28万元,占总成交额3.64%,散户资金净流出4.41万元,占总成交额0.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100010175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0177","300452","BK0239"],"gpt_icon":0},{"id":"2543609382","title":"6月16日山河药辅发布公告,股东减持161.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2543609382","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543609382?lang=zh_cn&edition=full","pubTime":"2025-06-16 23:04","pubTimestamp":1750086269,"startTime":"0","endTime":"0","summary":"证券之星消息,6月16日山河药辅发布公告《山河药辅:关于5%以上股东减持股份计划实施完毕的公告》,其股东上海复星医药产业发展有限公司于2025年4月4日至2025年6月10日间合计减持161.7万股,占公司目前总股本的0.6897%,变动期间该股股价上涨5.45%,截止6月10日收盘报12.96元。股东增减持详情见下表:根据山河药辅2025年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061600033705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0177","300452","BK0239"],"gpt_icon":0},{"id":"2531206155","title":"山河药辅收盘下跌1.00%,滚动市盈率23.77倍,总市值27.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531206155","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531206155?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:23","pubTimestamp":1745918607,"startTime":"0","endTime":"0","summary":"4月29日,山河药辅今日收盘11.84元,下跌1.00%,滚动市盈率PE达到23.77倍,总市值27.76亿元。从行业市盈率排名来看,公司所处的化学制药行业市盈率平均45.68倍,行业中值26.55倍,山河药辅排名第78位。资金流向方面,4月29日,山河药辅主力资金净流出521.22万元,近5日总体呈流出状态,5日共流出2137.49万元。最新一期业绩显示,2025年一季报,公司实现营业收入2.48亿元,同比4.28%;净利润4717.69万元,同比-5.30%,销售毛利率32.36%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/29172350001410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0177","BK0239","300452"],"gpt_icon":0},{"id":"2530944943","title":"山河药辅:作为国内药用辅料的领先者坚决作好制药企业应对国际变局的坚实后盾","url":"https://stock-news.laohu8.com/highlight/detail?id=2530944943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530944943?lang=zh_cn&edition=full","pubTime":"2025-04-25 11:36","pubTimestamp":1745552168,"startTime":"0","endTime":"0","summary":"证券之星消息,山河药辅(300452)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问:据微博知名医药行业达人伊洛牧今日所言,已经有国内集采医药品种,因为美国辅料大幅涨价乃至停止供应,可能要面临停产风险了。贵司有没有决心抓住机遇承担责任为国分忧加快药用辅料国产替代的工作。山河药辅回复:投资者你好,作为国内药用辅料的领先者,山河药辅将从技术、产能供应上,坚决作好制药企业应对国际变局的坚实后盾,给国内药企提供稳定、优质、高性价比的国产替代方案。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500018456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","01477","BK0177","BK1191","BK1574","300452"],"gpt_icon":0},{"id":"2530948029","title":"仿制药概念股回调,科伦药业跌逾5%,华东医药、海思科、山河药辅跌逾4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530948029","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530948029?lang=zh_cn&edition=full","pubTime":"2025-04-25 10:10","pubTimestamp":1745547028,"startTime":"0","endTime":"0","summary":"仿制药概念股回调,科伦药业跌逾5%,华东医药、海思科、山河药辅跌逾4%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/25101049864042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1064130708.USD","BK0187","LU1969619763.USD","LU2148510915.USD","BK0175","BK0209","BK0239","300452","BK0033","000963","LU2328871848.SGD","LU1064131003.USD","002422","BK0183","BK0177","BK0188","BK0060","002653","BK0077","BK0196","BK0028","BK0132"],"gpt_icon":0},{"id":"2529534725","title":"山河药辅(300452.SZ)发布2024年度业绩,归母净利润1.19亿元,同比下降26.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529534725","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529534725?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:38","pubTimestamp":1745311108,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)发布2024年年度报告,报告期内,公司实现营业收入8.83亿元,同比增长5.16%。实现归属于上市公司股东的净利润1.19亿元,同比下降26.07%。实现归属于上市公司股东的扣除非经常性损益的净利润1.01亿元,同比下降26.45%。基本每股收益为0.51元。拟向全体股东每10股派发现金红利3.00元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300452"],"gpt_icon":0},{"id":"2514554630","title":"再出手!复星医药产业拟减持山河药辅,这一次套现多少?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514554630","media":"投资时报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514554630?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:19","pubTimestamp":1740467943,"startTime":"0","endTime":"0","summary":"截至信息发布之时,复星医药产业持有山河药辅的股份总数约为2392.81万股,占山河药辅总股本的10.20%,为持股超过5%的重要股东。近年来,复星医药产业对山河药辅进行了多次减持操作。2024年6月底,基于自身经营需要,复星医药产业对外公布了减持山河药辅股份的计划。据此计算,复星医药产业通过此次减持共计套现约2770.27万元,其持有的山河药辅比例也相应从11.20%调整至10.20%。复星医药产业的减持动作对公司股价或存在影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251527279891d8fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251527279891d8fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0028","BK0175","BK0239","BK0060","BK0177","BK0196","BK0096","BK0187","BK0012","300452","600196","02196","BK0183"],"gpt_icon":0},{"id":"2513478517","title":"复星医药拟减持山河药辅不超3%股份市值腰斩聚焦核心业务加注AI医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2513478517","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513478517?lang=zh_cn&edition=full","pubTime":"2025-02-24 19:23","pubTimestamp":1740396210,"startTime":"0","endTime":"0","summary":"2024年7月31日至2024年10月8日,复星医药完成减持232.6万股,减持均价为11.91元/股。以此计算,复星医药套现约2770.27万元。目前,复星医药仍持有山河药辅2392.81万股,占该公司总股本比例为10.2%,为山河药辅第二大股东。业绩方面,2022年、2023年,复星医药连续两年净利润下滑,2024年前三季度净利润再度下滑11.93%至20.11亿元。不过,近年来,复星医药不断处理非核心非战略资产,集中资源聚焦核心业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224193248a251df5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224193248a251df5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300452","600196","BK0012","BK0188","BK0239","BK0096","BK0177","BK0028","BK0183","BK0187","BK0060","BK0196","159938","BK0175"],"gpt_icon":0},{"id":"2513759975","title":"山河药辅:股东复星医药因经营需要拟减持不超过3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513759975","media":"观点网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513759975?lang=zh_cn&edition=full","pubTime":"2025-02-23 23:11","pubTimestamp":1740323511,"startTime":"0","endTime":"0","summary":"观点网讯:山河药辅2月23日公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。 山河药辅表示,公司生产经营情况正常。本次拟减持股份的股东不属于公司的控股股东或实际控制人,本次股份减持不会导致公司控制权发生变更,不会对公司治理结构、股权结构及持续性经营产生影响。免责声明:本文内容与数据由观点根据公开信息整理,不构成投资建议,使用前请核实。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/23231148332588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","600196","BK0096","BK0177","BK0187","BK1515","BK0183","BK1593","BK0060","BK0196","BK1191","BK0012","BK0175","300452","BK0239","02196","BK0028"],"gpt_icon":0},{"id":"2513130758","title":"山河药辅(300452.SZ)股东复星医药拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2513130758","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513130758?lang=zh_cn&edition=full","pubTime":"2025-02-23 22:00","pubTimestamp":1740319219,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)发布公告,持股10.20%的股东上海复星医药产业发展有限公司(以下简称“复星医药”)因经营需要,拟自公告发布之日起15个交易日后90日内(2025年3月18日至2025年6月15日)以集中竞价交易方式和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0196","BK0060","BK1593","BK1191","BK0177","300452","BK0028","BK0183","02196","BK0096","BK0012","BK1515","BK0187","BK0188","BK0175","600196"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1756802326682,"stockEarnings":[{"period":"1week","weight":-0.0427},{"period":"1month","weight":-0.0447},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.2199},{"period":"1year","weight":0.2661},{"period":"ytd","weight":0.1574}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":0.0886},{"period":"3month","weight":0.1528},{"period":"6month","weight":0.1597},{"period":"1year","weight":0.3636},{"period":"ytd","weight":0.1563}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽山河药用辅料股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"17488人(较上一季度增加10.48%)","perCapita":"10681股","listingDate":"2015-05-15","address":"安徽省淮南市大通区经济技术开发区河滨路2号","registeredCapital":"23444万元","survey":" 安徽山河药用辅料股份有限公司的主营业务是药用辅料的研发、生产和销售。公司的主要产品是填充剂、黏合剂、崩解剂、润滑剂、包衣材料。“立崩”牌羧甲淀粉钠先后获得淮南市知名产品、安徽省名牌产品和“中国化学制药行业药用辅料优秀产品品牌”、首批“安徽工业精品”称号,羟丙甲纤维素荣获“中国化学制药行业优秀产品品牌”奖。微晶纤维素、硬脂酸镁和薄膜包衣粉产品被评定为淮南市知名产品,并有多个产品列入《中国高新技术产品出口目录》。公司多次获得“中国化学行业药用辅料优秀企业品牌”称号。","listedPrice":14.96},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"山河药辅(300452)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供山河药辅(300452)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"山河药辅,300452,山河药辅股票,山河药辅股票老虎,山河药辅股票老虎国际,山河药辅行情,山河药辅股票行情,山河药辅股价,山河药辅股市,山河药辅股票价格,山河药辅股票交易,山河药辅股票购买,山河药辅股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"山河药辅(300452)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供山河药辅(300452)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}